Good Info Allseeing...

Just checked into it....McConnell is part of the Senate Committee and I would think he would be there.....

I am going to tune in to listen to it....(it is audio feed only)...

Where are you getting your information on the Hemp Bill hitting the Senate floor today at 3:00?

TVR...
Good question. I am also a holder of KUSH and at their conference call held at the end of March, one of the things that was pointed out was that California got a very late start with permits, licenses and other paperwork associated with the various outlets getting inventory and selling. Their conference call covered the period Dec, 2017 Jan Feb of 2018

The sales increase was about 11% just as you pointed out, which tells me that the number of new locations they added (by my calculations would have been 250 or so) may have been predominantly in California and those locations may have made a buy from CVSI late in the quarter.

Thus, the sales reporting period would have been brief for these new locations.

I do recall reading in the news reports, that a lot of dispensary owners at the last minute had to pay additional fees for final approval to begin doing business.


The other question is the reporting of a sale by CVSI. Accounts receivable did not really vary at all, which tells me that they are reporting only cash sales PAID to them at point of purchase.

I can't say for sure that this is fact, but it seems to me that may have been the reason for the difference in new locations being increased by 18% and sales only increasing by 10-11%.

I would email someone in the company about it. On the conference calls they never seem to get to the questions because the call itself takes about 30 minutes or so.

Folks...(Ap in particular)

You got the two most powerful leaders on the Senate in agreement here. Furthermore, this bill is on the
Rule 14 Fast Track, which if you read up on it, means that this bill will not follow the normal path to passage. (meaning, that "Pistol Pete" may have nothing to do with this.)

What McConnell will probably do is add the language to the EXISTING farm bill. That means less debate and typical congressional bureaucracy.

This is about trade deficit, jobs, farmers and exporting versus importing which is big on both sides of the party aisle.

It's rare that Schumer and McConnell agree on anything....but in this case this is big because of the implications it has and keep in mind Pelosi's son is the chairman of the board of Freedom Leaf Inc....which is a marijuana legalization company.

So.....what do you think is going to happen here?...

I don't know what your position with CVSI is....but I do know this.....20% of the people have 80% of the money.....those that can read the tea leaves are the ones that are going to make money on these opportunities...

The farmers need help right now.....McConnell knows it, Schumer knows it and a whole bunch of other Senators and Congressional people know it...

This is an election year folks.....things get done in election years.....

Remember......Money ........follows.........Money...........and when the Banks get involved as the Hemp bill allows for......THAT..........will blow the lid off of the whole sector.

Mona's status with the company is irrelevant to the stock price and the performance of the company.

Bottom line, what ever the settlement will be it will be. CVSI will handle it, but for those of you who think that Mona's stepping down is the key "trigger point" for this stock you are sadly mistaken.

His presence as a CEO is already factored in to the stock price action we are seeing.

What will matter come Thursday is what the 4th Qtr. sales were, what profit if any was made in the 4th Qtr, and what does the cash position look like and what the debt service is with respect to the toxic loans out there.

By my calculation I think we have a little over $300K in a tranche payment left. I also tend to believe that the cash position of company should be improving . In the last press release, Mona indicated that the company cash position was strong enough to handle the outstanding debt.

The question is where are they with the FDA and CVSI 007 and how soon will it be accepted in to the "fast track" program for the various phases and human trials.

The first quarter of 2018 is ending March 31, and the next report that we will see should be a barn burner as a result of the first quarter of California sales with respect to the retail side of the business which is keeping the company going.

The big question here with CVSI 007 is how much money it will take to bring the drug through the process of Phase I - IV of the FDA.....

We may see some profitability short term, but may be in a whirlwind cycle of all of the ups and downs associated with the FDA. The money CVSi would be making, going forward may need to be invested in the drug development.

Those of you who own GW Pharmaceuticals and Twenty Second Century group know exactly what I am talking about.....these companies are constantly dumping money into the development of their respective drug candidates to get the final approval by the FDA. Both of them are very close.

CBD and it's status is still an unknown and DEA doesn't like it and FDA is not sure what to think of it.

McConnell's bill mayl help, but I would not count on it being the "catalyst" for a run in the stock price.. If you read the article about the bill, he still has to have a conversation with Sessions to get him on board.

I wouldn't be concerned about that store Captain. 1500 locations prior to California, 6 months of expansion in Nevada, Massachusetts coming on board....Maine, etc...

I am hoping they can keep up with the production and distribution required to get all the CBD products out into the market.

The gum is the key product, if it can pass FDA approvals, the retail of the Plus CBD line in of itself will make this company very profitable....

Xavier Becerra is the AG for California......doesn't look like any enforcement likely to happen....

Love the last line on the segment....."Give it your best shot"


http://www.cnn.com/2018/01/05/politics/is-the-white-house-declaring-a-policy-war-on-california/index.html

From the Deputy Director Gottlieb on November 29...


"The aim is to make sure FDA has the right policies in place to enable the development of product innovations that have the potential to be more helpful in helping smokers quit combustible cigarettes and maintain abstinence. This could include changes to the labeling and indications for existing products or a new product that might deliver nicotine at different rates, or through different delivery mechanisms entirely. To enable innovation, FDA might contemplate additional approaches to developing these products, including new clinical trial endpoints."

The big key statement here is the last sentence. In particular, "new clinical trial endpoints"

Seems to me, unlike other types of drugs that take years of the clinical phase protocols, NRT's (Nicotine Replacement Therapy" alternatives will take far less time for fast track approvals then conventional drugs.

Although the reference in the statement refers to cigarettes, tobacco addiction via smokeless tobacco is just as concerning to the FDA as is cigarettes. Bottom line is they both cause death no matter whether you chew or smoke.

Agree with Bud on his post. This may be factored in to the price and it could result in a stock price fluctuation as result.

Mona should step down immediately, or the board needs to vote him out. If he doesn't then CVSI would assume a lot of PR liabilities that could be very damaging to other investors. One being the continuation of being in the news and the ongoing litigation and the legal expense that CVSI would incur defending this.

Like many government agencies, this might seem slow in the development in bringing the case forward by the SEC, however they do their homework and make absolutely certain of their case/position before they file charges.

In reading the filing, it is quite apparent what he did and the worst part about it is CANV repeatedly filed false reports.

He needs to resign his position immediately.

None of this affects the FDA's position in the evaluation of the CVSI 007....We will know more on July 14, once we see whether it receives 505b2 pathway status or not.

The focus now is getting this smokeless tobacco IND through the FDA and to market.

FDA has thirty (30) days to respond to request for 505b2 pathway.

We should know by July 15, 2017 the status.

Regarding CVSI 007:

This in my opinion is the home run offering for CVSI. CVSI 008 will be 3-5 years as it would have to go through standard FDA protocols for approval to market.

CVSI 007 is unique in respect that neither Chantax, or Nicoderm nicotine treatment programs deal with smokeless tobacco addiction. That is the angle and the path that CVSI is pursuing as it fits the FDA description of "unmet need". (You can go to the FDA website and read about the FDA fast track program criteria).

The beauty of fast track (assuming the FDA accepts the filing and grants the classification) is that the company will have more frequent interaction with the FDA and if all goes well can move through the various phases I, II, III, IV and V...

I is drug development
II is Preclinical Research
III Clinical Research
IV FDA Review
V FDA Post Market Safety Monitoring

The requirements for fast track are

Serious Condition

Unmet Medical Need
For this classification, the the drug (CVSI 007) needs to meet the FDA definition which is that there is no therapy for treatment for the condition (In this case smokeless tobacco addiction).

Details on this are on the FDA website. Google FDA fast track and you will see it.

The hope for all of us is that the FDA grants the company fast track designation, the actual gum and the components that make it up do no harm to anyone shows efficacy, and the clinical trials prove to be successful.

All that said, the patent for the make up of this smokeless tobacco gum substitute becomes extremely valuable, such to a point where a big pharmaceutical company wishes to add it to repertoire and either buys out CanX (the pharmaceutical division of CVSI) for a nice price.

The smokeless tobacco problem is real in this country and neither current smoking cessation player currently is dealing with it.

The June 15 meeting is the first step. The FDA will take up to 30 days before CVSI will be granted permission to conduct clinical trials.

What is positive for us is that we are not dealing with a weight loss drug or a blood pressure drug or new form of a pain medication, I have been down that road with other stocks, two that made it...and several that did not.

I suspect that because of the CBD compound in the gum and the other components in it, that the process hopefully will be free of reactions, complications or censure by independent boards for various reasons and that clinical trials are stopped.

What we are all hoping for is positive clinical trials that prove out EFFICACY.

The gum of which you are speaking about is a smoking cessation gum. That product already exists. There are gums out there (Nicorette) that deal with smoking cessation.

The market for which CVSI 007 is targeting is "smokeless tobacco, the kind of chewing tobacco that baseball players frequently engage in and was most recently talked about with the US Department of Defense.

I think it's important to really understand that (in my opinion,) the CVSI 007 gum is the key to the success of the company.

CBD margins are very slim, and many companies are producing it. although none better that CVSI. They have received a number of awards for their CBD oil quality.

Lots of confusion out there in the market place with respect to CBD and whether a vitamin store wishes to carry it or not. Many may not be sure of what action to take with respect to retailing.

Joe Dowling mentions in his presentation what the company's premier product is. To refresh your memory go back and you tube it and watch it again. That's the focus of CVSI. It is the smokeless tobacco epidemic, and the fact that CVSI is addressing it as an "unmet need" which the FDA recognizes for a possible evaluation and fast track protocols.

If you are concerned about the hemp business, the CBD business and the retail effects of their products being the key, then you didn't understand the presentations that Joe Dowling has been giving. He has given at least two presentations on the smokeless tobacco market which is what they are pursuing.

Please excuse the typos on post 8588....

Seems to me most people don't really understand CV Sciences and its real objective long term.

Did anyone listen to the webinar by Joe Dowling? Did anyone read the shareholder letter by Mona in September?

In late December last year, they acquired CanX which is a bio-tech pharmaceutical company for the express purpose of their goal. That, being the approval of a CBD infused gum for the treatment of smokeless tobacco addiction. Currently there is no company attempting to develop this type of drug for this express purpose. There is NO company that sells a product for this type of addiction.

There are two major players in the smoking cessation space. Chantix and Nicoderm. Both of these companies carry "Black Box" warnings. Essentially there are major side effects with these drugs. These companies DO NOT attempt to deal in the smokeless tobacco space.

Read Mona's letter. He tells you what steps the company has taken to far. They are pursuing the FDA 505 fast track pathway. Read the information from the link below or go to Goggle and enter FDA fast track in the search. You will find it.

www.fda.gov/forpatients/approvals/fast/ucm20041766.htm



California, Nevada, Maine, Mass, all passed recreational use, and those markets, and this will undoubtedly create more customers on the retail side so that their natural retail CBD products will be in more stores. Keep in mind, may vitamin stores in the US and certainly in those 4 states, were unwilling to accept CBD type products because of the stigma associated with Marijuana and the perception. That is now changed. Remember......Money will follow money. Certainly we should expect to see more sales in this division over time with the addition of these 4 new states.

I followed FDA approval process with two weight loss drugs back in 2010. VVUS and ARNA. Both of these companies went through the long term approval process of about 3-4 years and in the end, VVUS went from a penny stock of about .80 cents a share to a high $31.00 in July of 2012. ARNA went from about $2.00 bucks a share, to about $13.00

The CBD gum falls under the "unmet need" definition within the FDA. Therefore we should see a very quick interaction within the FDA with respect to the gum and it's effectiveness. As was pointed out in the webinar, there are no side effects with the product being designed by the Company.

Ideally, we want to see a progression through the FDA trials, through each and every phase with FDA approving each clinical phase along the way.

With a proprietary drug formula that could be significantly effective treating this unmet need, you don't need to be a rocket scientist to figure out what other "interested parties" might want to get involved in CVSI. That is where the real upside is. Thats why I am an investor.

I don't see any significant movement in the stock until the interaction begins with the FDA and subsequent reports follow. The fact that they are the only company in a 5.3 billion dollar space designing such a drug for this unmet need is really a very dynamic opportunity for significant shareholder value.

This is old news, but just wondering who the Institutional Holder is that has 0.0192 pct of CVSI. Anyone know who that might be?

I don't have an issue with the compensation program at all. If you look at the deal they are not getting the options until they complete certain criteria.

Basically, this as I see it, is totally incentive based as well it should be. I think that when the company gets the ball rolling with the FDA with respect to its CBD processing and formula applications, it then will position itself very nicely for an acquisition or merger.

Their CBD oil is of extremely high quality, and very likely will (if not already) attract other major players in the Big Pharm space.

One of the pivotal keys to all of this is to get the DEA to reschedule marijuana to Schedule 2 status. Then the CBD research market can get going and thats where the home run will be.

The election this year is very critical for these types of things. Getting more states to recognize the value of commercializing marijuana, and its value as a taxable commodity also will play big.

The other key is what type of new administration is in the White House. Those who follow politics know that Clinton is far more relaxed about marijuana and its handling on a state by state basis.

Trump on the other hand also has no problem with it on a state basis. However, if he chooses Christie as a running mate and wins, the whole marijuana industry will definitely be stonewalled.

Christie as those who know him is very anti marijuana. Including research for medical purposes.

Great article.

It really explains what is on the horizon and more importantly why.

Agree with your assessment Marty;

Financials don't always move stock price....unless its really significant...both up or down

Look for serious movement once news breaks regarding the DEA and what they do with the reclassifying of marijuana from Schedule 1 to 2..



That will be the first big movement maker in my opinion.

The next big news will be on Nov 8 when the election results are in regarding the consensus of the voters in the states that have marijuana on the ballot for either medical/recreational or both.


This is a matter of time folks......the momentum is going forward.....

Some valid points.....I agree....

What takes care of their needs is simply sales.......and that is what they are working on....the 24 million is for the 2016 inventory needs...not this year........the...Capital Raises are not uncommon....although I am not sure they will lose market share....

To me.....they don't need to be the dominant player......just like beer....lots of beer makers out there......many of them making money....

CBD oil needs to have quality in order for GNC or Vitamin Shoppe to want to make a huge purchase.....and many players in the CBD oil market right now...are not really sure what they are selling to their customers because they can't validate the quality of the product...and the FDA has begun shutting down websites making medical claims off of CBD.....

If $1.00 investors are selling their shares now....then good for them....they are entitled to. I am not one of those types....I see the 2 - 3 year deal.....once Cannavest lands a few big customers in the bag....they will begin to gain traction in the market......That's one of the roles of Stuart Tomc the VP of nutrition has with the company....he is well known in the vitamin industry.....and that is one of his main goals......

At the recent supply show they had a few weeks ago, Cannavest took numerous order information and the presentation room was SRO with wholesalers and marketers...

The big players in the Vitamin industry are ready to move on CBD....vitamin companies are always in search of the "next best thing"...Once they feel comfortable with their wholesale vendor....(and we want them to be a Cannavest customer)....then the game is on.....and like any product.....how quickly can you get it to market....

Again......making your observations about the movement of this stock at this level and at the current level of this company's growth is fine....but a little too early for speculation.

I have seen many a company take on debt service with capital notes to pay....stick to their game plans.....and then the tipping point in the industry happens and they are ready for the success.

To me....they are one big event away from traction.....and then a few more things fall into place and then the true success that they will achieve will happen..

Would I like them to dominate the market ? Sure....but do they have to to make money for all of the stock holders.?...absolutely not...

Your points are valid detective......and I see you are a sharp critic......but I can't tell you how many times I went against many experts...like a Jim Cramer on CNBC I made lots of money...not listening to him....

The biggest enemy to all investors is two things....FEAR and GREED......you need to know how to handle those emotions....

Time........will tell all.........it always does......

Detective...

You sound like a quick hit artist on this stock.....This a growing company...sales are vastly improved...

I am in it for the 2-3 year deal......thats where the money is.....this is a long term play...you sound a little panicked....

I have 6 months restriction on my stock....not one year...

Here is what I know and what I see...

They are getting new customers in the pipeline interested in their CBD and other hemp products.....

So...sales will continue to increase.....and so will profits

All the legislation out there is headed in one direction legalization and states one by one taking it into their own hands for at the very least tax revenue.....you cannot ignore the taxation power of hemp and marijuana.....there is too much money on the line....

When I first bough Apple many years ago....I remember the general feeling was that they would never be able to compete with Microsoft....

Now what do you see? Apple vs Microsoft....No comparison...and Microsoft has more computers running windows then people running Macs......yet look at the market caps...

So...you show me another publicly traded company that is positioned like Cannavest is....there are very few.....they have a quality product.......and they will get the resources necessary to fund the sales that they have to service...


If you guys are going to watch this stock every day and bitch about all the wrong reasons...why its not at $4 and $6 and so on.....you are wasting your time with this stock...this is a growth play....2 years or 3....and investors like myself who are patient (like I was with Apple)...will be rewarded handsomely .....but if you are going to stalk this stock.....you need to move on....

I see 4 grams per container and 10 grams per container.....but you can call Stuart Tomc at Cannavest....and he will tell you where to find it....or tell you how much is in each container....

I agree ...it should be disclosed.....

619-876-4545..

Rifleshaft....

Detective,

Thanks for your input. Let me give you my perspective on the capital raise.

First, I should tell you that I made a substantial investment through the private placement at $2.00 per share. I have done this before with companies, and have done well 4 out of 6 times.....

The very first question I ask when I am considering investing is right out of the book from Sharktank
"What do you need the money for"?

17 million of the 24 million is needed to fill orders for the 2016 year. Thats what investors want to see. Money that will be used to service sales. If you can't fill orders because you are short of cash, then you can't make money.

Had they said they wanted to use the money for R & D or other testing or product testing or evaluation, I would have gone the other way.

Investors want to see their money being put to work making more money. The bottom line with Cannavest, and the industry in general, is that there is too much money here on the line to simply have each State govt and Federal govt turn its back on the legalization of the crop.

Cannavest is not on that side of the ledger....they are on the nutrient side of the hemp plant. The development of the various products and especially the development of CBD which continually shows promise to stop and at the very least curtail seizures in children.

Rand Pauls bill along with McConnell and the other bi partisan supporters is all about jobs for the farmers.....and we all know how bad the farmers are hurting.

State govts, are not about to continue to tax it's citizens any further....the resources that are available now with respect to hemp and the legalization of marijuana and the revenue that is generated is too strong....

Remember....Money follows Money.......Colorado Washington, and now 4 other states are getting involved.....23 states have legalized medical marijuana...Cannavest just needs to have the development of the hemp plant as crop....it does not need to have marijuana legalized to be successful.....If however that happens...then that will be the double home run......

This is all about public perception......if 61% of the country thinks marijuana should be legal then how many think that hemp farming and its benefits should be legal?

You see......No one is asking that question......

And that my friend is inevitably going to happen.....

Folks...very normal stock behavior for Private Placement news.

The shares for private placement are six month restricted.

Seems like a lot of short players here......and if you are in at $1-2 and looking to make a killing at $5-6.....you'll be missing the boat....

This is a long play here folks......once the stock moves north...next stop will be NASDAQ....and eventually the shorts will be squeezed out....

Shorts is what it is.....short term...long is what it is......long term...

You can't accumulate wealth shorting the market...or selling too prematurely